全民健康保險價量協議法律問題分析

Translated title of the contribution: Legal Issues of Price-Volume Agreements in National Health Insurance

Research output: Contribution to journalArticle

Abstract

Price-volume agreements (PVAs) are negotiations between pharmaceutical companies and the government or payer in a national healthcare system. The government or payer can ask price cuts or rebates when the actual sales exceed a forecasted volume. PVAs have been adopted internationally in recent years. In Taiwan, PVAs are still in an early stage of development, and their legal status has not been clearly defined by the National Health Insurance Act. This essay argues that PVAs should be regarded as a subtype of administrative contracts from legal and policy perspectives. To ensure PVAs' legal validity, the National Health Insurance Administration should reexamine existing PVAs and correct some clauses.
Translated title of the contributionLegal Issues of Price-Volume Agreements in National Health Insurance
Original languageTraditional Chinese
Pages (from-to)381-417
Number of pages37
Journal臺大法學論叢
Volume43
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint Dive into the research topics of 'Legal Issues of Price-Volume Agreements in National Health Insurance'. Together they form a unique fingerprint.

  • Cite this